Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 229Leukemia, Lymphocytic, Chronic, B-Cell 213Leukemia 203Myelodysplastic Syndromes 182Precursor Cell Lymphoblastic Leukemia-Lymphoma 174Lymphoma, Non-Hodgkin 121Lymphoma 120Hodgkin Disease 108Multiple Myeloma 107Lymphoma, Follicular 100Lymphoma, Mantle-Cell 99Lymphoma, Large B-Cell, Diffuse 86Lymphoma, B-Cell, Marginal Zone 85Congenital Abnormalities 85Myeloproliferative Disorders 84Burkitt Lymphoma 81Leukemia, Myelomonocytic, Chronic 77Leukemia, Myelogenous, Chronic, BCR-ABL Positive 75Leukemia, Myeloid, Chronic-Phase 74Leukemia, Myeloid, Accelerated Phase 73Lymphoma, Large-Cell, Immunoblastic 61Anemia, Refractory, with Excess of Blasts 60Blast Crisis 55Primary Myelofibrosis 53Waldenstrom Macroglobulinemia 52Neoplasms, Plasma Cell 52Recurrence 48Hematologic Neoplasms 45Dendritic Cell Sarcoma, Interdigitating 42Leukemia, Prolymphocytic 41

Interventions

AP 1903 reagent 3ON 01910 2Biopsy 2thymoglobulin 1fludarabine phosphate 1fludarabine 1epacadostat 1Specimen Handling 1Sertraline 1Peripheral Blood Stem Cell Transplantation 1Metformin 1IDO-1 inhibitor LY3381916 1Granulocyte Colony-Stimulating Factor 1Genetic Counseling 1Filgrastim 1Cyclophosphamide 1Cord Blood Stem Cell Transplantation 1Busulfan 1Bone Marrow Transplantation 1Ascorbic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cytopenia × fludarabine phosphate × Other hematologic neoplasm × Clear all
NCT02143830 2025-11-12

RAFA

Children's Hospital Medical Center, Cincinnati

Phase 2 Recruiting
70 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Cytopenia, Anemia, Refractory, with Excess of Blasts, Fanconi Anemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡